Fibromyalgia — Mollii Suit and Fibromyalgia (EXOFIB 2)
Citation(s)
Annemans L, Le Lay K, Taieb C Societal and patient burden of fibromyalgia syndrome. Pharmacoeconomics. 2009;27(7):547-59. doi: 10.2165/11313650-000000000-00000.
Bengtsson A, Henriksson KG The muscle in fibromyalgia--a review of Swedish studies. J Rheumatol Suppl. 1989 Nov;19:144-9.
Bocerean C, Dupret E A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry. 2014 Dec 16;14:354. doi: 10.1186/s12888-014-0354-0.
Burwinkle T, Robinson JP, Turk DC Fear of movement: factor structure of the tampa scale of kinesiophobia in patients with fibromyalgia syndrome. J Pain. 2005 Jun;6(6):384-91. doi: 10.1016/j.jpain.2005.01.355.
Busner J, Targum SD The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007 Jul;4(7):28-37.
Campbell WI, Lewis S Visual analogue measurement of pain. Ulster Med J. 1990 Oct;59(2):149-54.
Cleeland CS, Ryan KM Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap. 1994 Mar;23(2):129-38.
Coskun Benlidayi I The effectiveness and safety of electrotherapy in the management of fibromyalgia. Rheumatol Int. 2020 Oct;40(10):1571-1580. doi: 10.1007/s00296-020-04618-0. Epub 2020 Jun 10.
Da Silva TFG, Suda EY, Marçulo CA, Paes FHS, Pinheiro GT Comparison of transcutaneous electrical nerve stimulation and hydrotherapy effects on pain, flexibility and quality of life in patients with fibromyalgia [Comparação dos efeitos da estimulação elétrica nervosa transcutânea e da hidroterapia na dor, flexibilidade e qualidade de vida de pacientes com fibromialgia]. Fisioterapia e Pesquisa 2008;15:118-24.
Drewes AM, Andreasen A, Schroder HD, Hogsaa B, Jennum P Pathology of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultrastructural study. Br J Rheumatol. 1993 Jun;32(6):479-83. doi: 10.1093/rheumatology/32.6.479.
Elvin A, Siosteen AK, Nilsson A, Kosek E Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: a contrast media enhanced colour Doppler study. Eur J Pain. 2006 Feb;10(2):137-44. doi: 10.1016/j.ejpain.2005.02.001.
Faul F, Erdfelder E, Lang AG, Buchner A G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. doi: 10.3758/bf03193146.
Ghavidel-Parsa B, Bidari A, Amir Maafi A, Ghalebaghi B The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects. Korean J Pain. 2015 Jul;28(3):169-76. doi: 10.3344/kjp.2015.28.3.169. Epub 2015 Jul 1.
Johnson MI, Claydon LS, Herbison GP, Jones G, Paley CA Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev. 2017 Oct 9;10(10):CD012172. doi: 10.1002/14651858.CD012172.pub2.
Kahl C, Cleland J Visual Analogue Scale, Numeric Rating Scale and the McGill Pain Quesitonniare: An Overview of Psychometric Properties. Phys Ther. 2005;10:123.
Marques AP, Assumpcao A, Matsutani LA, Pereira CA, Lage L Pain in fibromyalgia and discrimination power of the instruments: Visual Analog Scale, Dolorimetry and the McGill Pain Questionnaire. Acta Reumatol Port. 2008 Jul-Sep;33(3):345-51.
Okifuji A, Hare BD Management of fibromyalgia syndrome: review of evidence. Pain Ther. 2013 Dec;2(2):87-104. doi: 10.1007/s40122-013-0016-9. Epub 2013 Sep 21.
Park JH, Phothimat P, Oates CT, Hernanz-Schulman M, Olsen NJ Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis Rheum. 1998 Mar;41(3):406-13. doi: 10.1002/1529-0131(199803)41:33.0.CO;2-L.
Perneger TV, Leplege A, Etter JF, Rougemont A Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol. 1995 Aug;48(8):1051-60. doi: 10.1016/0895-4356(94)00227-h.
Riachi N, Khazen G, Ahdab R, Jörgen S Pain reducing properties of the Mollii suit on adults with chronic pain syndromes. J. Neurol. Sci. 2019;405:138-139
Schmidt-Wilcke T, Clauw DJ Fibromyalgia: from pathophysiology to therapy. Nat Rev Rheumatol. 2011 Jul 19;7(9):518-27. doi: 10.1038/nrrheum.2011.98.
Schmidt-Wilcke T, Diers M New Insights into the Pathophysiology and Treatment of Fibromyalgia. Biomedicines. 2017 May 13;5(2):22. doi: 10.3390/biomedicines5020022.
Steffen TM, Hacker TA, Mollinger L Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther. 2002 Feb;82(2):128-37. doi: 10.1093/ptj/82.2.128.
Taylor SJ, Steer M, Ashe SC, Furness PJ, Haywood-Small S, Lawson K Patients' perspective of the effectiveness and acceptability of pharmacological and non-pharmacological treatments of fibromyalgia. Scand J Pain. 2019 Jan 28;19(1):167-181. doi: 10.1515/sjpain-2018-0116.
Wolfe F, Brahler E, Hinz A, Hauser W Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken). 2013 May;65(5):777-85. doi: 10.1002/acr.21931.
Wolfe F, Walitt BT, Hauser W What is fibromyalgia, how is it diagnosed, and what does it really mean? Arthritis Care Res (Hoboken). 2014 Jul;66(7):969-71. doi: 10.1002/acr.22207. No abstract available.
The Effects of EXOPULSE Mollii Suit on Fibromyalgia Syndrome in Patients With Fibromyalgia (EXOFIB 2): A Sham Controlled Randomized Double-Blind Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.